Hipolin

Which are the latest news on Hipolin?

Why is Hipolin Ltd falling/rising?

As of 05-Sep, Hipolin Ltd's stock price is at 76.69, reflecting a 0.35% decrease and a 26.67% decline over the past seven days. The stock is underperforming against the Sensex and shows short-term weakness despite increased investor participation.

As of 05-Sep, Hipolin Ltd's stock price is falling, currently at 76.69, which reflects a decrease of 0.27 or 0.35%. The stock has been on a downward trend, losing value for the last seven consecutive days, resulting in a significant decline of 26.67% over this period. Additionally, the stock has underperformed compared to the benchmark Sensex, with a 1-week return of -18.80% against the Sensex's -0.97%. <BR><BR>In terms of moving averages, the stock is currently higher than its 200-day moving average but lower than its 5-day, 20-day, 50-day, and 100-day moving averages, indicating a short-term weakness. Despite this, there has been a notable increase in investor participation, with delivery volume rising by 244.47% on September 3 compared to the 5-day average, suggesting some interest from investors. However, the overall performance and consecutive declines indicate that the stock is currently in a bearish phase.

Should I buy, sell or hold Hipolin Ltd?

Who are in the management team of Hipolin?

The management team of Hipolin includes Shaileshkumar Jayantilal Shah (Chairman/Executive Director), Daxesh B Shah, Samir Rohit Shah, Dimpal Sheth (all Executive Directors), and several Independent Non-Executive Directors: Nitaben Bharatbhai Shah, Ajay R. Gandhi, Umesh P. Mehta, and Avni Chouhan.

The management team of Hipolin includes the following members:<BR><BR>1. **Shaileshkumar Jayantilal Shah** - Chairman / Executive Director<BR>2. **Daxesh B Shah** - Executive Director<BR>3. **Samir Rohit Shah** - Executive Director<BR>4. **Nitaben Bharatbhai Shah** - Independent Non-Executive Director<BR>5. **Ajay R. Gandhi** - Independent Non-Executive Director<BR>6. **Umesh P. Mehta** - Independent Non-Executive Director<BR>7. **Dimpal Sheth** - Executive Director<BR>8. **Avni Chouhan** - Independent Non-Executive Director and Additional Independent Director<BR><BR>If you need more details about any specific member or their roles, feel free to ask!

What does Hipolin do?

Hipolin Ltd is a micro-cap company in the FMCG sector, incorporated in 1994, with net sales of 5 Cr and a market cap of INR 31 Cr as of June 2026. It has a low debt-equity ratio of 0.05 but a negative return on equity of -10.69%.

Overview:<BR>Hipolin Ltd operates in the Fast-Moving Consumer Goods (FMCG) sector and is categorized as a micro-cap company.<BR><BR>History:<BR>Hipolin was incorporated on 31 March 1994. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 5 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 0 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 31 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 44 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.05 <BR>Return on Equity: -10.69% <BR>Price to Book: 4.00<BR><BR>Contact Details:<BR>Address: A/1/1 Nilkanth Indus Estate, Sanand - Viramgam Highway Virochannagar Gujarat : 382170 <BR>Tel: 91-2717-284202 <BR>Email: hipolin@hipolin.com <BR>Website: http://www.hipolin.com

Who are the peers of the Hipolin?

Hipolin's peers include Sanwaria Consum., Healthy Life, Dindigul Farm, Chordia Food, Tyroon Tea Co., Kanco Tea, and Sinnar Bidi Udy. Most peers exhibit below-average management risk and growth, with Healthy Life showing the highest negative return at -80.44%.

Peers: The peers of Hipolin are Sanwaria Consum., Healthy Life, Dindigul Farm, Chordia Food, Tyroon Tea Co., Kanco Tea, and Sinnar Bidi Udy.<BR><BR>Quality Snapshot: Below Average management risk is observed at all peers, including Sanwaria Consum., Healthy Life, Dindigul Farm, Chordia Food, Tyroon Tea Co., Kanco Tea, Sinnar Bidi Udy, and Hipolin. For growth, Excellent growth is noted at Healthy Life, Good growth at Dindigul Farm, and the rest have Below Average growth. In terms of capital structure, Good capital structure is found at Tyroon Tea Co., while Average capital structure is at Healthy Life, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: Healthy Life has the highest 1-year return at -80.44%, while Hipolin has a 1-year return that is not available. Hipolin's 1-year return cannot be compared directly, but it is noted that several peers, including Healthy Life, Dindigul Farm, and Sinnar Bidi Udy, have negative six-month returns.

How big is Hipolin?

As of 31st August, Hipolin Ltd has a market capitalization of 31.00 Cr, with recent net sales of 16.08 Cr and a net profit loss of 0.04 Cr over the last four quarters. Shareholder's funds are valued at 8.14 Cr, and total assets amount to 12.98 Cr.

As of 31st August, <BR><BR>Market Cap: Hipolin Ltd has a market capitalization of 31.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 16.08 Cr, while the sum of Net Profit for the same period is a loss of 0.04 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 8.14 Cr, and Total Assets amount to 12.98 Cr.

Are Hipolin Ltd latest results good or bad?

Hipolin Ltd's latest results show a small net profit of ₹0.01 crore in Q4 FY26, a significant improvement from a loss last year, but revenue has declined by 10.45% year-on-year. While there are signs of recovery, ongoing revenue erosion and a negative return on equity indicate that the company's financial health remains concerning, warranting cautious investor consideration.

Hipolin Ltd's latest results present a mixed picture. On one hand, the company has achieved a net profit of ₹0.01 crore in Q4 FY26, a significant improvement compared to a loss of ₹2.36 crores in the same quarter last year. This indicates a positive shift in profitability, albeit marginal. The operating margin has also turned positive at 0.51%, recovering from a deeply negative -52.95% a year ago.<BR><BR>However, the revenue has declined by 10.45% year-on-year to ₹3.94 crores, which continues a troubling trend of revenue erosion. While there was a slight sequential improvement of 4.79% from the previous quarter, this is not enough to offset the overall downward trajectory. The company's return on equity (ROE) remains concerning at -49.53%, indicating significant inefficiencies and value destruction for shareholders.<BR><BR>Overall, while Hipolin's ability to post a small profit is a step in the right direction, the ongoing revenue decline, minimal profitability, and negative return ratios suggest that the company's financial health is still precarious. Investors should approach with caution, as the underlying issues may overshadow the recent marginal recovery.

When is the next results date for Hipolin Ltd?

The next results date for Hipolin Ltd is 14 February 2026.

The next results date for Hipolin Ltd is scheduled for 14 February 2026.

How has been the historical performance of Hipolin?

Hipolin's historical performance shows increasing net sales from 12.22 Cr in Mar'22 to 21.56 Cr in Mar'25, but rising expenditures have led to negative operating profits and a decline in profitability, with a profit before tax of -3.28 Cr in Mar'25. The company also faces challenges in cash flow, reporting -3.00 Cr from operating activities.

Answer:<BR>The historical performance of Hipolin shows a fluctuating trend in its financial metrics over the past four years.<BR><BR>Breakdown:<BR>Hipolin's net sales have increased from 12.22 Cr in Mar'22 to 21.56 Cr in Mar'25, indicating a positive growth trajectory. However, total expenditure has also risen significantly, from 13.46 Cr in Mar'22 to 24.88 Cr in Mar'25, leading to a negative operating profit (PBDIT) of -3.32 Cr in Mar'25, compared to -1.24 Cr in Mar'22. The company reported a profit before tax of -3.28 Cr in Mar'25, down from a profit of 7.63 Cr in Mar'23, reflecting a substantial decline in profitability. The total assets decreased from 16.28 Cr in Mar'24 to 12.98 Cr in Mar'25, while total liabilities also fell from 16.28 Cr to 12.98 Cr in the same period. Cash flow from operating activities has remained negative, with -3.00 Cr reported in Mar'25, indicating ongoing challenges in generating cash from operations. Overall, while Hipolin has shown growth in sales, it faces significant challenges in managing costs and profitability.

Is Hipolin overvalued or undervalued?

As of April 25, 2023, Hipolin is considered risky and overvalued due to its negative PE ratio of -8.55, poor returns on capital and equity, and significant underperformance compared to industry peers and the Sensex.

As of 25 April 2023, Hipolin's valuation grade has moved from does not qualify to risky, indicating a significant deterioration in its financial health. The company is currently overvalued, as evidenced by its negative PE ratio of -8.55 and an EV to EBITDA ratio of -8.97, which are starkly unfavorable compared to industry peers. Additionally, Hipolin's ROCE stands at -34.00% and ROE at -40.05%, reflecting substantial inefficiencies in generating returns.<BR><BR>In comparison to its peers, such as Hindustan Unilever with a PE ratio of 53.88 and Nestle India at 75.2, Hipolin's financial metrics are alarmingly poor. The EV to Sales ratio of 1.38 also suggests that investors are paying a premium for a company that is struggling to generate profits. Notably, Hipolin's stock has underperformed significantly against the Sensex, with a year-to-date return of -43.47% compared to the Sensex's 5.63%, reinforcing the perception of overvaluation.

What is the technical trend for Hipolin?

As of June 2, 2025, Hipolin's technical trend is mildly bearish, with mixed signals from various indicators, including bearish moving averages and Bollinger Bands, contrasted by some mildly bullish weekly indicators.

As of 2 June 2025, the technical trend for Hipolin has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals across time frames. The Bollinger Bands are bearish on both weekly and monthly charts, and daily moving averages also reflect a bearish trend. The KST shows a mildly bullish weekly outlook but is mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance with a mildly bullish monthly view. The OBV is mildly bearish weekly but bullish monthly, adding to the mixed signals. Overall, the current technical stance is mildly bearish, driven primarily by bearish moving averages and Bollinger Bands, despite some mildly bullish indicators on the weekly time frame.

Who are the top shareholders of the Hipolin?

The top shareholder of Hipolin is Kinnari Vaibhav Shah, owning 18.75%, with promoters holding a total of 39.76% pledged shares. Public shareholders include Arunaben Manherlal Vakil at 1.65%, while individual investors collectively hold 23.17%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Hipolin primarily consist of promoters, with Kinnari Vaibhav Shah holding the largest share at 18.75%. The promoters collectively have a pledged holding of 39.7627%. In terms of public shareholders, Arunaben Manherlal Vakil is the highest individual shareholder, owning 1.65%. Additionally, individual investors collectively hold 23.17% of the company. Notably, there are currently no mutual funds or foreign institutional investors (FIIs) holding shares in Hipolin.

Has Hipolin declared dividend?

Hipolin Ltd has declared a 10% dividend, amounting to 1.0000 per share, but the dividend yield is 0%. While recent short-term returns are negative, long-term returns have shown significant growth.

Hipolin Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: Sep-23-2010<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -48.32%, the dividend return was 0%, resulting in a total return of -48.32%.<BR><BR>For the 1-year period, the price return was -29.69%, the dividend return was 0%, leading to a total return of -29.69%.<BR><BR>Over the 2-year period, the price return was -2.0%, the dividend return was 0%, which resulted in a total return of -2.0%.<BR><BR>In the 3-year period, the price return was 139.02%, the dividend return was 0%, culminating in a total return of 139.02%.<BR><BR>For the 4-year period, the price return was 159.41%, the dividend return was 0%, resulting in a total return of 159.41%.<BR><BR>In the 5-year period, the price return was 375.47%, the dividend return was 0%, leading to a total return of 375.47%.<BR><BR>Overall, while Hipolin Ltd has declared a dividend, the dividend yield is 0%, indicating that the dividend does not contribute to the returns in recent periods. The total returns show significant fluctuations, with strong positive returns over longer periods despite negative returns in the short term.